- Home
- HSON vs BOLD Comparison
HSON vs BOLD Comparison
Compare HSON & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSON
- BOLD
- Stock Information
- Founded
- HSON 1999
- BOLD 2018
- Country
- HSON United States
- BOLD United States
- Employees
- HSON N/A
- BOLD N/A
- Industry
- HSON Professional Services
- BOLD
- Sector
- HSON Consumer Discretionary
- BOLD
- Exchange
- HSON Nasdaq
- BOLD Nasdaq
- Market Cap
- HSON 23.1M
- BOLD 24.4M
- IPO Year
- HSON N/A
- BOLD 2024
- Fundamental
- Price
- HSON $8.78
- BOLD $1.18
- Analyst Decision
- HSON
- BOLD Buy
- Analyst Count
- HSON 0
- BOLD 3
- Target Price
- HSON N/A
- BOLD $4.00
- AVG Volume (30 Days)
- HSON 9.5K
- BOLD 105.5K
- Earning Date
- HSON 08-07-2025
- BOLD 08-11-2025
- Dividend Yield
- HSON N/A
- BOLD N/A
- EPS Growth
- HSON N/A
- BOLD N/A
- EPS
- HSON N/A
- BOLD N/A
- Revenue
- HSON $138,031,000.00
- BOLD N/A
- Revenue This Year
- HSON $0.80
- BOLD N/A
- Revenue Next Year
- HSON $8.09
- BOLD N/A
- P/E Ratio
- HSON N/A
- BOLD N/A
- Revenue Growth
- HSON N/A
- BOLD N/A
- 52 Week Low
- HSON $8.26
- BOLD $1.00
- 52 Week High
- HSON $18.48
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- HSON 61.11
- BOLD N/A
- Support Level
- HSON $8.77
- BOLD N/A
- Resistance Level
- HSON $9.19
- BOLD N/A
- Average True Range (ATR)
- HSON 0.34
- BOLD 0.00
- MACD
- HSON 0.09
- BOLD 0.00
- Stochastic Oscillator
- HSON 62.90
- BOLD 0.00
About HSON Hudson Global Inc.
Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.